nordazepam has been researched along with Fibrosis in 1 studies
Nordazepam: An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.
nordazepam : A 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety.
Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
| Excerpt | Relevance | Reference |
|---|---|---|
| " administration the kinetics of total chlordesmethyldiazepam in patients with liver disease differed from those in controls: elimination half-life was almost twice that in controls (395 and 204 h), as a consequence of a marked reduction in total clearance (0." | 2.68 | Effects of liver disease on the pharmacokinetics of intravenous and oral chlordesmethyldiazepam. ( Bareggi, SR; Devis, G; Pirola, R; Potvin, P, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bareggi, SR | 1 |
| Pirola, R | 1 |
| Potvin, P | 1 |
| Devis, G | 1 |
1 trial available for nordazepam and Fibrosis
| Article | Year |
|---|---|
Effects of liver disease on the pharmacokinetics of intravenous and oral chlordesmethyldiazepam.
Topics: Administration, Oral; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Female; Fibrosis; Human | 1995 |